Methods for reduction of cohesive forces between carrier and drug in DPI formulation

References

• Smith IJ, Parry-Billings M. (2003). The inhalers of the future? A review of dry powder devices on the market today. Pulm Pharmacol Ther, 16:79–95.
   PubMed Web of Science ®Google Scholar
• Hickey AJ, Dunbar CA. (1997). A new millennium for inhaler technology. Pharm Technol, 21:116–125.
   Google Scholar
• Dekker FW, Dieleman FE, Kaptein AA, Mulder JD. (1993). Compliance with pulmonary medication in general practice. Eur Respir J, 6:886–890.
   PubMed Web of Science ®Google Scholar
• Bisgaard H. (1996). Drug delivery from inhaler devices. BMJ, 313:895–896.
   PubMed Web of Science ®Google Scholar
• Swarbrick J. (2007). Encyclopedia of pharmaceutical technology. 3rd ed. New York: Informa Healthcare, Inc.
   Google Scholar
• Peart J, Clarke MJ. (2003). New developments in DPI Technology. Am Pharm Rev, 37–45.
   Google Scholar
• Larhrib H, Martin GP, Prime D, Marriott C. (2003). Characterisation and deposition studies of engineered lactose crystals with potential for use as a carrier for aerosolised salbutamol sulfate from dry powder inhalers. Eur J Pharm Sci, 19:211–221.
   PubMed Web of Science ®Google Scholar
• Chan HK, Chew NY. (2003). Novel alternative methods for the delivery of drugs for the treatment of asthma. Adv Drug Deliv Rev, 55:793–805.
   PubMed Web of Science ®Google Scholar
• Gibson M. (2004). Pharmaceutical preformulation and formulation – a practical guide from candidate drug selection to commercial dosage form. Boca Raton: CRC Press.
   Google Scholar
• Zeng XM, Martin AP, Marriott C, Pritchard J. (2000). The influence of carrier morphology on drug delivery by dry powder inhalers. Int J Pharm, 200:93–106.
   PubMed Web of Science ®Google Scholar
• Dickhoff BH, de Boer AH, Lambregts D, Frijlink HW. (2005). The interaction between carrier rugosity and carrier payload, and its effect on drug particle redispersion from adhesive mixtures during inhalation. Eur J Pharm Biopharm, 59:197–205.
   PubMed Web of Science ®Google Scholar
• de Boer AH, Dickhoff BH, Hagedoorn P, Gjaltema D, Goedeb J, Lambregts D, Frijlink HW. (2005). A critical evaluation of the relevant parameters for drug redispersion from adhesive mixtures during inhalation. Int J Pharm, 294:173–184.
   PubMed Web of Science ®Google Scholar
• Saint-Lorant G, Leterme P, Gayot A, Flament MP. (2007). Influence of carrier on the performance of dry powder inhalers. Int J Pharm, 334:85–91.
   PubMed Web of Science ®Google Scholar
• Flament MP, Leterme P, Gayot A. (2004). The influence of carrier roughness on adhesion, content uniformity and the in vitro deposition of terbutaline sulphate from dry powder inhalers. Int J Pharm, 275:201–209.
   PubMed Web of Science ®Google Scholar
• Banker GS, Rhodes CT. (2002). Modern pharmaceutics. 4th ed. New York: Marcel Dekker, Inc, 486–488.
   Google Scholar
• Harjunen P, Lehto VP, Martimo K, Suihko E, Lankinen T, Paronen P et al. (2002). Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI. Eur J Pharm Sci, 16:313–321.
   PubMed Web of Science ®Google Scholar
• Lucas P, Anderson K, Potter UJ, Staniforth JN. (1999). Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive. Pharm Res, 16:1643–1647.
   PubMed Web of Science ®Google Scholar
• Guchardi R, Frei M, John E, Kaerger JS. (2008). Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations. Int J Pharm, 348:10–17.
   PubMedGoogle Scholar
• Staniforth JN. (2000). Carrier particles for use in dry powder inhalers. US Patent No. US6153224.
   Google Scholar
• Liversidge GG, Cundy KC, Bishop JF, Czekai DA. (1992). Surface modified drug nanoparticles. US Patent No. US5145684.
   Google Scholar
• Gilani K, Rouholamini Najafabadi A, Barghi M, Rafiee-Tehrani M. (2004). Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers. Eur J Pharm Biopharm, 58:595–606.
   PubMed Web of Science ®Google Scholar
• Chidavaenzi OC, Buckton G, Koosha F. (2001). The effect of co-spray drying with polyethylene glycol 4000 on the crystallinity and physical form of lactose. Int J Pharm, 216:43–49.
   PubMed Web of Science ®Google Scholar
• Kumon M, Suzuki M, Kusai A, Yonemochi E, Terada K. (2006). Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC. Chem Pharm Bull, 54:1508–1514.
   PubMed Web of Science ®Google Scholar
• Larhrib H, Martin GP, Marriott C, Prime D. (2003). The influence of carrier and drug morphology on drug delivery from dry powder formulations. Int J Pharm, 257:283–296.
   PubMed Web of Science ®Google Scholar
• Telko MJ, Hickey AJ. (2005). Dry powder inhaler formulation. Respir Care, 50:1209–1227.
   PubMedGoogle Scholar
• Giry K, Péan JM, Giraud L, Marsas S, Rolland H, Wüthrich P. (2006). Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation. Int J Pharm, 321:162–166.
   PubMedGoogle Scholar
• Maa YF, Nguyen PA, Sweeney T, Shire SJ, Hsu CC. (1999). Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res, 16:249–254.
   PubMed Web of Science ®Google Scholar
• Vegala SP. (2004). Preparation of pharmaceutical powders using supercritical fluid technology. Pharmaceutical applications and physicochemical characterization of powders (dissertation). Uppsala Univ.
   Google Scholar
• Whelan J. (2002). Electronic DPI for insulin. Drug Discov Today, 7:213–214.
   PubMed Web of Science ®Google Scholar
• Parthiban S, Steve M, Truman C, McNair D, Smyth H. (2011). Micronized drug adhesion and detachment from surfaces: Effect of loading conditions. Aerosol Sci Technol, 45:81–87.
   Web of Science ®Google Scholar